Ablation treatments in unresectable pancreatic cancer.

Published on Jan 2, 2019in Minerva Chirurgica0.765
· DOI :10.23736/S0026-4733.18.07881-1
Salvatore Paiella23
Estimated H-index: 23
Matteo De Pastena12
Estimated H-index: 12
+ 7 AuthorsRoberto Salvia23
Estimated H-index: 23
(University of Verona)
: Ablation treatments have been increasingly applied as an alternative treatment for unresectable locally advanced pancreatic cancer (LAPC). The goal of LAPC therapy is surgical resection with negative margins (R0); however, that can be achieved only in a minority of patients and only following neoadjuvant treatment. Ablation might be useful for those patients with unresectable LAPC that do not progress towards metastatic stage and do not experience a true downstaging. Indeed, some LAPC that tend to grow locally, might be the subgroup of tumors that could benefit from ablation. Experience is necessary to select patients and the technique to adopt, since serious or fatal complications can occur. This review aims to discuss the role of ablation treatments in LAPC, with a unique focus on radiofrequency ablation and irreversible electroporation.
📖 Papers frequently viewed together
2 Citations
8 Citations
#1Guo Tian (ZJU: Zhejiang University)H-Index: 20
#2Xueping Liu (ZJU: Zhejiang University)H-Index: 1
Last. Tian'an Jiang (ZJU: Zhejiang University)H-Index: 9
view all 5 authors...
Background. Pancreatic cancer (PC) is a deadly disease with poor prognosis in the general population. We aimed to quantitate overall survival of patients with PC after irreversible electroporation (IRE) and the incidence of relevant complications. Methods. We performed a literature search via five electronic databases (PubMed, Embase, Web of Science, Scopus, and Cochrane Library databases) up to August 2017. The primary outcomes were overall survival and prognosis. Secondary outcomes included th...
5 CitationsSource
BACKGROUND AND AIMS: Endoscopic ultrasound-guided radiofrequency ablation (EUS-RFA) is a promising technique for the treatment of pancreatic neoplasm. We evaluated the feasibility, safety, and technical success of pancreatic EUS-RFA performed in a single center. METHODS: 9 consecutive patients (8 with pancreatic adenocarcinoma and 1 with renal cancer metastasis) were referred for EUS-RFA between November 2016 and July 2017. EUS-RFA was performed using 18-gauge internally cooled electrode with a ...
26 CitationsSource
#1Pascal HammelH-Index: 86
#2Jill Lacy (Yale University)H-Index: 26
Last. Philip A. Philip (WSU: Wayne State University)H-Index: 76
view all 12 authors...
204Background: In the phase 3 MPACT study, treatment with nab-P + G resulted in a > 3-fold reduction in primary pancreatic tumor burden vs G in patients with metastatic PC, suggesting the potential for activity against LAPC. This international, multicenter single arm, phase 2 trial (LAPACT) was designed to evaluate the efficacy and safety of an induction phase regimen of nab-P + G in previously untreated patients with LAPC. Methods: Treatment-naive patients with unresectable LAPC and Eastern Coo...
23 CitationsSource
#1Thomas J. Vogl (Goethe University Frankfurt)H-Index: 83
#2Bita Panahi (Goethe University Frankfurt)H-Index: 5
Last. L Basten (Goethe University Frankfurt)H-Index: 3
view all 8 authors...
To evaluate the clinical performance of percutaneous microwave ablation (MWA) for treatment of locally-advanced-pancreatic-cancer (LAPC).Twenty-two MWA sessions (August 2015-March 2017) in 20 patients with primary pancreatic cancer (13 men, 7 women, mean-age: 59.9 ± 8.6 years, range: 46-73 years), who had given informed consent, were retrospectively evaluated. All procedures were performed percutaneously under CT-guidance using the same high-frequency (2.45-GHz) MWA device. Tumor location and di...
9 CitationsSource
#1Alessandro GiardinoH-Index: 12
#2Giulio Innamorati (University of Verona)H-Index: 21
Last. Claudio Bassi (University of Verona)H-Index: 110
view all 12 authors...
Abstract Objective/Background RFA of pancreatic cancer has been demonstrated to be feasible and safe with a positive impact on survival. The aim was to investigate whether an immune reaction is activated after locally advanced pancreatic cancer (LAPC) ablation. Methods Peripheral Blood samples were obtained preoperatively and on post-operative days 3–30. Evaluated parameters were: cells [CD4+, CD8+ and activated subsets, T-Reg, Monocytes, myeloid and plasmocytoid Dendritic cells (mDC and pDC)] a...
22 CitationsSource
#1Salvatore Paiella (University of Verona)H-Index: 23
#1Salvatore Paiella (University of Verona)
Last. Roberto Salvia (University of Verona)H-Index: 52
view all 16 authors...
Purpose SMAD4 mutational status correlates with pancreatic ductal adenocarcinoma (PDAC) failure pattern. We investigated in a subset of locally advanced patients submitted to radiofrequency ablation (RFA) whether the assessment of SMAD4 status is a useful way to select the patients.
8 CitationsSource
#1Margaret A. Tempero (UCSF: University of California, San Francisco)H-Index: 59
#2Mokenge P. Malafa (Moffitt Cancer Center)H-Index: 20
Last. Susan DarlowH-Index: 22
view all 36 authors...
Abstract Ductal adenocarcinoma and its variants account for most pancreatic malignancies. High-quality multiphase imaging can help to preoperatively distinguish between patients eligible for resection with curative intent and those with unresectable disease. Systemic therapy is used in the neoadjuvant or adjuvant pancreatic cancer setting, as well as in the management of locally advanced unresectable and metastatic disease. Clinical trials are critical for making progress in treatment of pancrea...
429 CitationsSource
#1Daniel Ansari (Lund University)H-Index: 25
#2Stina Kristoffersson (Lund University)H-Index: 1
Last. Magnus Bergenfeldt (Lund University)H-Index: 12
view all 4 authors...
AbstractObjectives: Irreversible electroporation (IRE) is a new modality for tumor ablation. Electrodes are placed around the tumor, and a pulsed, direct current with a field strength of 2000 V/cm is delivered. The direct current drives cells into apoptosis and cell death without causing significant heating of the tissues, which spares the extracellular matrix and proteins. The purpose of this review was to evaluate current experience of IRE for the ablation of pancreatic cancer.Material and met...
34 CitationsSource
#1Mathilde Wagner (Paris IV: Paris-Sorbonne University)H-Index: 20
#1Mathilde Wagner (Paris IV: Paris-Sorbonne University)H-Index: 1
Last. Jean-Baptiste BachetH-Index: 35
view all 8 authors...
Aim To assess anatomic changes on computed tomography (CT) after neoadjuvant FOLFIRINOX (5-fluorouracil/leucovorin/irinotecan/oxaliplatin) chemotherapy for secondary resected borderline resectable (BR) and locally advanced (LA) pancreatic adenocarcinoma and their accuracy to predict resectability and pathological response.
52 CitationsSource
#1Mirko D'Onofrio (University of Verona)H-Index: 58
#2Stefano Crosara (University of Verona)H-Index: 15
Last. Roberto Pozzi Mucelli (University of Verona)H-Index: 38
view all 8 authors...
Aim:The objective of this study was to evaluate the efficacy of percutaneous radiofrequency ablation of locally advanced pancreatic cancer located in the pancreatic body.Materials and Methods:Patients with biopsy-proven locally advanced pancreatic adenocarcinoma were considered for percutaneous radiofrequency ablation. Postprocedural computed tomography studies and Ca19.9 tumor marker evaluation were performed at 24 hours and 1 month. At computed tomography, treatment effect was evaluated by exc...
25 CitationsSource
Cited By6
#1Raffaella Casolino (Glas.: University of Glasgow)H-Index: 2
#2Chiara Braconi (Glas.: University of Glasgow)H-Index: 28
Last. Talia Golan (Sheba Medical Center)H-Index: 20
view all 11 authors...
This review summarises the recent evidence on preoperative therapeutic strategies in pancreatic cancer and discusses the rationale for an imminent need for a personalized therapeutic approach in non-metastatic disease. The molecular diversity of pancreatic cancer and its influence on prognosis and treatment response, combined with the failure of "all-comer" treatments to significantly impact on patient outcomes, requires a paradigm shift towards a genomic-driven approach. This is particularly im...
1 CitationsSource
#1Roberto SalviaH-Index: 1
Last. Salvatore PaiellaH-Index: 23
view all 3 authors...
#1Sabrina Gloria Giulia Testoni (UniSR: Vita-Salute San Raffaele University)H-Index: 10
#2Gabriele Capurso (UniSR: Vita-Salute San Raffaele University)H-Index: 56
Last. Paolo Giorgio Arcidiacono (UniSR: Vita-Salute San Raffaele University)H-Index: 40
view all 16 authors...
Background and study aims Endoscopic ultrasound (EUS)-guided ablation of pancreatic ductal adenocarcinoma (PDAC) with HybridTherm-Probe (EUS-HTP) is feasible and safe, but the radiological response and ideal tool to measure it have not been investigated yet. The aims of this study were to: 1) assess the radiological response to EUS-HTP evaluating the vital tumor volume reduction rate, Response Evaluation Criteria in Solid Tumors (RECIST1.1) and Choi criteria; 2) determine the prognostic predicti...
#1Yusef MoullaH-Index: 9
#2TO PetersenH-Index: 3
Last. Ines GockelH-Index: 43
view all 12 authors...
Hintergrund Das lokal fortgeschrittene, irresektable (nichtmetastasierte) und grenzwertig resektable Pankreaskarzinom stellt eine therapeutische Herausforderung dar. Zur lokalen Behandlung in diesen Situationen stehen verschiedene minimal-invasive lokal ablative Verfahren zur Verfugung.
1 CitationsSource
#1Yusef MoullaH-Index: 9
#2TO Petersen (Leipzig University)H-Index: 3
Last. Ines GockelH-Index: 43
view all 12 authors...
Bei einem der Koautoren ist leider der Name nicht korrekt geschrieben worden. Es handelt sich um Nikolaos Bailis.
Abstract Purpose As an alleviative treatment measured in patients with unresectable advanced pancreatic cancer, radiofrequency ablation (RFA) needed more clinical data to prove its advantages and to explore limitations in its utilization. This study was determined to observe the efficacy of RFA, and to explore its impact on perioperative periphery carcinoma as well as the normal pancreatic tissues. Methods Clinical data of 32 patients with pancreatic cancer accepted RFA surgery were collected. F...
#1F. Ausania (University of Barcelona)H-Index: 3
#1F. Ausania (University of Barcelona)H-Index: 8